Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

611 projects found matching your search criteria :

  1. Electrospun plant-based polymer patches for hormones and probiotics multistage targeted delivery

    Call: OPUS 29 , Panel: ST11

    Principal investigator: prof. Urszula Stachewicz

    Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie

  2. Functional nanomaterials based on drug–lipid–ligands as targeted delivery systems for anticancer agents in lung adenocar...

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Piotr Paweł Szyk

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  3. Characterization of microscopic fungi isolated from human cadavers.

    Call: PRELUDIUM 24 , Panel: NZ8

    Principal investigator: Klaudyna Aleksandra Spychała

    Uniwersytet Wrocławski

  4. Surface-functionalized lipid-based nonlamellar nanoparticles as carriers for peptide antibiotics.

    Call: OPUS 29 , Panel: ST4

    Principal investigator: dr hab. Ewa Nazaruk

    Uniwersytet Warszawski

  5. Titanium Dioxide in a New Light: Reducing Toxicity and Improving the Photoprotective Properties of TiO2 Through Nanopart...

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Michał Jan Gackowski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  6. Modelling of amorphous and nanocrystalline structure of bulk metallic glasses for explain their functional properties

    Call: SONATA 2 , Panel: ST8

    Principal investigator: dr Rafał Babilas

    Politechnika Śląska, Wydział Mechaniczny Technologiczny

  7. Development of novel 1,3-selenazol-2-one derivatives incorporated into self-emulsifying drug delivery systems as a strat...

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: dr hab. Robert Czarnomysy

    Uniwersytet Medyczny w Białymstoku

  8. "Green" Bioactive Dual-Layer Dressing for Controlled Neurotrophin and Analgesic Release to Support Nerve Regeneration in...

    Call: PRELUDIUM 24 , Panel: ST5

    Principal investigator: Anna Beata Zakrzewska

    Instytut Podstawowych Problemów Techniki Polska Akademia Nauk

  9. High Internal Phase Pickering Emulsions Stabilized with Solid Particles for Encapsulation of Lipophilic Drugs and Oxygen...

    Call: PRELUDIUM 24 , Panel: ST8

    Principal investigator: Weronika Adriana Kieres

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

  10. Hydrothermal surface phosphorylation as the key to the ideal implant – a new generation of implants capable of releasing...

    Call: PRELUDIUM 24 , Panel: ST11

    Principal investigator: Marcel Jakubowski

    Politechnika Poznańska

  11. Structural engineering of cell-penetrating peptides into biostable antibacterials to combat drug-resistant pathogens

    Call: OPUS 29 , Panel: NZ1

    Principal investigator: prof. Joanna Dominika Trylska

    Uniwersytet Warszawski

  12. Pharmaceuticals in Sediments: Effects on Benthic Organisms under Climate Change Scenarios (SEDIPHARM)

    Call: OPUS 29 , Panel: NZ8

    Principal investigator: dr hab. Joanna Giebułtowicz

    Warszawski Uniwersytet Medyczny

  13. Design and Pharmacological Evaluation of Marine Alkaloid-Inspired 5-HT2A Receptor Ligands

    Call: PRELUDIUM 24 , Panel: NZ1

    Principal investigator: Szymon Kazimierz Kordylewski

    Instytut Farmakologii PAN

  14. Smart Multiscale Encapsulation System: Hydrogel Macrocapsules with LbL Nanoparticles for Colorectal Cancer Treatment

    Call: PRELUDIUM 24 , Panel: ST11

    Principal investigator: Joanna Irena Szechyńska

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

  15. Therapeutic evaluation of anti-fibrotic agents for thyroid eye disease (TED) in a preclinical mouse model

    Call: PRELUDIUM 24 , Panel: NZ6

    Principal investigator: Paweł Franciszek Tyrna

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

  16. NMR Spectroscopy as Molecular Language: A Deep Learning Approach to Bioactivity Prediction

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Arkadiusz Bogumił Leniak

    Instytut Farmakologii PAN

  17. Analysis of the use of medicines containing psychotropic substances of the IV-P group, emphasis on anxiolytic and hypnot...

    Call: SONATA 2 , Panel: NZ7

    Principal investigator: dr Anna Patrycja Gołda

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  18. Preparation of pollen-like advanced drug delivery carriers for the treatment of chronic obstructive pulmonary disease

    Call: SHENG 4 , Panel: ST5

    Principal investigator: prof. Elżbieta Pamuła

    Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie

  19. Neuroplasticity regulation by alternative gene transcription

    Call: SONATA 2 , Panel: NZ3

    Principal investigator: dr Michał Korostyński

    Instytut Farmakologii PAN

  20. Precisie quantum chemical calculations for light atomic and molecular systems

    Call: OPUS 1 , Panel: ST4

    Principal investigator: dr Mariusz Puchalski

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

  21. A new strategy to fight antibiotic resistance based on hybrids of fluoroquinolones and quaternary ammonium salts

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Joanna Dagmara Fedorowicz

    Gdański Uniwersytet Medyczny

  22. Investigating the properties of 3d–printed polymeric membranes as personalized dressings for hard-to-heal wounds.

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Ewelina Zofia Baran

    Uniwersytet Pedagogiczny im. Komisji Edukacji Narodowej w Krakowie

  23. Light-responsive biowaste-based sustainable 3D platform withon-demand drug release against bacterial infections in acute...

    Call: SONATA 20 , Panel: ST5

    Principal investigator: dr Alicja Kosik-Kozioł

    Instytut Podstawowych Problemów Techniki Polska Akademia Nauk

  24. Janus nanoparticles - research on the effect of the duality of carriers of the activesubstance in targeted therapy of sk...

    Call: OPUS 28 , Panel: ST8

    Principal investigator: dr hab. Bożena Anna Tyliszczak

    Politechnika Krakowska im. Tadeusza Kościuszki

  25. Advancing Skeletal Muscle Tissue Engineering: Biologically Active Bioinks for Drug-Induced Disease Modelling and On-Dema...

    Call: OPUS 28 , Panel: ST8

    Principal investigator: prof. Wojciech Święszkowski

    Politechnika Warszawska

  26. In vitro cultures of Trifolium rubens L. – phytochemical, biotechnological studies and evaluation of biological activity...

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Marta Karolina Klimek-Szczykutowicz

    Uniwersytet Jana Kochanowskiego w Kielcach

  27. New Horizons in Cancer Immunotherapy: Blocking LAG-3/FGL1 Interactions

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Jacek Plewka

    Uniwersytet Jagielloński

  28. Investigation of the mechanism of enhanced liposome delivery to tumors and its application for dual target immunotherapy

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr hab. Tomasz Piotr Rygiel

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  29. Smart Piezoelectric Bio-based Osteochondral Construct as a Model for Drug Testing and Implantation into Joint Defects

    Call: M-ERA.NET 3 Call 2024 , Panel: ST11

    Principal investigator: dr hab. Dorota Kołbuk-Konieczny

    Instytut Podstawowych Problemów Techniki Polska Akademia Nauk

  30. Could fibroblast senescence and their resistance to apoptosis be the hidden drivers behind endometrial fibrosis in equin...

    Call: OPUS 28 , Panel: NZ5

    Principal investigator: dr Katarzyna Karolina Piotrowska-Tomala

    Instytut Rozrodu Zwierząt i Badań Żywności PAN

  31. Microbial degradation of cardiac drugs: discovering the degradation pathways of one of the most commonly used beta-block...

    Call: SONATA 20 , Panel: NZ9

    Principal investigator: dr Anna Maria Dzionek

    UNIWERSYTET ŚLĄSKI

  32. "Integrated Fixed-Dose Combination Drugs in Depression Therapy: A New Standard of Treatment and Mechanism of Action Stud...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: prof. Gabriel Piotr Nowak

    Instytut Farmakologii PAN

  33. The first antibody-drug conjugates for Alzheimer's disease therapy

    Call: SONATA BIS 14 , Panel: NZ5

    Principal investigator: dr hab. Marcin Łukasz Poręba

    Politechnika Wrocławska

  34. Demonstration of the key role of vitamin B12 uptake in regulating Mycobacterium tuberculosis virulence lipids synthesis ...

    Call: SONATA BIS 14 , Panel: NZ6

    Principal investigator: dr Jakub Pawełczyk

    Instytut Biologii Medycznej PAN

  35. Molecular analyses of human dihydrouridine synthases acting on tRNA

    Call: SONATA BIS 14 , Panel: NZ1

    Principal investigator: dr Monika Ewelina Gaik

    Uniwersytet Jagielloński

  36. Personal_TIVA: A Personalized Approach To An Automatic Drugs Delivery Control System In The Total Intravenous Anaesthesi...

    Call: SONATA BIS 14 , Panel: ST7

    Principal investigator: dr hab. Andrzej Pawłowski

    Politechnika Wrocławska

  37. Supramolecular nanoparticles able to block calcium channels in cancer cells

    Call: SONATA BIS 14 , Panel: ST11

    Principal investigator: dr hab. Marek Brzeziński

    Centrum Badań Molekularnych i Makromolekularnych PAN

  38. Quad-TNT: Quadruplex-Targeted Photo-Therapy for Triple-Negative Tumors

    Call: SONATA BIS 14 , Panel: NZ5

    Principal investigator: dr Marco Deiana

    Politechnika Wrocławska

  39. A Fungal Hit Discovery Platform

    Call: JPIAMR ACTION Call 2024 , Panel: NZ1

    Principal investigator: dr Maria Magdalena Klimecka

    Uniwersytet Warszawski

  40. M6A RNA methylation signatures as a targets for HPV-dependent HNSCC therapy

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: Kamila Ostrowska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  41. Biological activity of AmB: Are the dynamics of interaction with the cell membrane the key?

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Sebastian Janik

    Uniwersytet Marii Curie-Skłodowskiej w Lublinie

  42. The influence of tunicamycin analogues and mimetics on hepatitis C virus (HCV) propagation.

    Call: PRELUDIUM 2 , Panel: NZ6

    Principal investigator: dr Ewelina Król

    Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

  43. Dual Se-containing 5-HT1A and 5-HT7 biased agonists activating sigma-1 receptor as a hope of finding fast-acting antidep...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: prof. Karolina Anna Pytka

    Uniwersytet Jagielloński

  44. Disruption of the posttranslational activation of the translation factor EF-P as a new target for antimicrobial agents.

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: dr Piotr Wilk

    Uniwersytet Jagielloński

  45. Strong bonds make perfect relationships. Covalent interactions between antibiotics and polymeric matrix as a key factor ...

    Call: PRELUDIUM 23 , Panel: ST5

    Principal investigator: Konrad Wojciech Kwiecień

    Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie

  46. Development of novel screening method for identifying xanthine oxidase inhibitors – towards new drug candidates for gout...

    Call: PRELUDIUM 23 , Panel: ST4

    Principal investigator: Monika Katarzyna Rola

    Politechnika Łódzka

  47. Nanocrystalline and amorphous light-weight complex concentrated alloys of Mg-Al-Ti-Fe-Cr type

    Call: OPUS 27 , Panel: ST11

    Principal investigator: dr hab. Marek Maciej Krasnowski

    Politechnika Warszawska

  48. Assessment of long-term effects of semaglutide administered in repeated short cycles in obese mice

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: dr hab. Jakub Łukasz Wojcieszak

    Uniwersytet Medyczny w Łodzi

  49. The role of gut microbiota in the treatment of epilepsy: experimental studies

    Call: OPUS 27 , Panel: NZ4

    Principal investigator: prof. Piotr Wiktor Wlaź

    Uniwersytet Marii Curie-Skłodowskiej w Lublinie

  50. Development of novel potential therapeutics in inflammatory bowel diseases based on nanoformulations employing senomodul...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: prof. Jakub Jerzy Fichna

    Uniwersytet Medyczny w Łodzi

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy